Karlyn Martin is a Hematology physician affiliated with University of Vermont. OpenAlex indexes 99 publications with 2,191 citations (h-index 18); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
111 Colchester Ave
Burlington, VT 054011473
Telephone
802-847-0000Provider last certified this registry record 28 Sept 2023.
Clinical trials
- Implementing VTE Prevention in Ambulatory Cancer Care
Sponsor: University of Vermont
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year20251 payment
- Penumbra, Inc.Program year20251 payment
- Endovascular Engineering Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
77.4%Factor Xa inhibitor66.1%Eliquis82%Xarelto18%Part D<11 patientsLow Molecular Weight Heparin11.3%Enoxaparin Sodium100%Part D<11 patientsCancer & immunology
22.6%Antimetabolite22.6%Hydroxyurea100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2024–2026 per NIH RePORTER. The latest:
- Implementing Prevention of Venous Thromboembolism for Ambulatory Patients with Cancer (PREVenT-APC)
University of Vermont & St Agric College
FY2026$164,678K23HL157758 - Implementing Prevention of Venous Thromboembolism for Ambulatory Patients with Cancer (PREVenT-APC)
University of Vermont & St Agric College
FY2025$165,794K23HL157758 - Implementing Prevention of Venous Thromboembolism for Ambulatory Patients with Cancer (PREVenT-APC)
University of Vermont & St Agric College
FY2024$166,323K23HL157758
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Risk factors for venous thrombosis after discharge from medical hospitalizations: the Medical Inpatient Thrombosis and Hemostasis study
Journal of Thrombosis and Haemostasis
2025 - Anticoagulation and other risk factors for clinically relevant bleeding after medical hospitalization: the Medical Inpatient Thrombosis and Hemostasis Study
Journal of Thrombosis and Haemostasis
2025
Similar KOLs
Other experts from the same institution or the same specialty.
David Schneider, MD
University of Vermont
Beth Kirkpatrick, MD
University of Vermont
Richard Page
University of Vermont
Martin Lewinter, MD
University of Vermont
Joseph Antin, MD
Harvard University
Scott Kaufmann, MD
Mayo Clinic College of Medicine
Jeffrey Miller, MD
University of Minnesota Medical School
Ruben Mesa, MD
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”